Tissue valve is the preferred option for patients aged 60 and older

Circulation

Volumn 128, Issue 12, 2013, Pages 1365-1371

  Kaneko, Tsuyoshi ^a   Cohn, Lawrence H ^a   Aranki, Sary F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; THROMBIN INHIBITOR; WARFARIN;

ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BLEEDING; CAUSE OF DEATH; DRUG SAFETY; EMBOLISM PREVENTION; FOLLOW UP; GERIATRIC CARE; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HUMAN; LIFE EXPECTANCY; MEDICAL DEVICE COMPLICATION; PATIENT PREFERENCE; PRIORITY JOURNAL; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; STRUCTURAL VALVE DEGENERATION; SURGICAL MORTALITY; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION;

ANIMALS; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CATTLE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SWINE;

EID: 84884272652     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.002584     Document Type: Article

References (53)

1. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137:82-90.
2. Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS, O'Brien SM, Brown JM. Trends in Mitral Valve Surgery in the United States: Results From The Society of Thoracic Surgeons Adult Cardiac Database. Ann Thorac Surg. 2009;87:1431-1439.
3. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. ACC/AHA 2008 Guidelines for the Management of Patients With Valvular Heart Disease. Circulation. 2008;114:e84-e231.
4. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, DeBonis M, Evangelista G, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HA, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease. Euro Heart J. 2012;33:2451-2496.
5. O xenham H, Bloomfield P, Wheatley DJ, Lee RJ, Cunningham J, Prescott RJ, Miller HC. Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart. 2003;89:715-721.
6. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152-1158.
7. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med. 1991;324:573-579.
8. Hammermeister KE, Henderson WG, Burchfiel CM, Sethi GK, Souchek J, Oprian C, Cantor AB, Folland E, Khuri S, Rahimtoola S. Comparison of outcome after valve replacement with a bioprosthesis versus a mechanical prosthesis: initial 5 year results of a randomized trial. J Am Coll Cardiol. 1987;10:719-732.
9. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart valve replacement with a mechanical valve or bioprosthesis. N Engl J Med. 1993;328: 1289-1296.
10. Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N, Vosa C. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol. 2009;54:1862-1868.
11. Hanania G, Michel PL, Montely JM, H. Warembourg, O. Nardi. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve in patients between 60 and 70 years of age. J Am Coll Cardiol. 2002;39:S423A.
12. Brown ML, Schaff HV, Lahr BD, Mullany CJ, Sundt TM, Dearani JA, McGregor CG, Orszulak TA. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg. 2008;135:878-84; discussion 884.
13. Khan SS, Trento A, DeRobertis M, Kass RM, Sandhu M, Czer LS, Blanche C, Raissi S, Fontana GP, Cheng W, Chaux A, Matloff JM. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg. 2001;122:257-269.
14. Chan V, Jamieson WR, Germann E, Chan F, Miyagishima RT, Burr LH, Janusz MT, Ling H, Fradet GJ. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. J Thorac Cardiovasc Surg. 2006;131:1267-1273.
15. Kulik A, Bédard P, Lam BK, Rubens FD, Hendry PJ, Masters RG, Mesana TG, Ruel M. Mechanical versus bioprosthetic valve replacement in middle-aged patients. Eur J Cardiothorac Surg. 2006;30:485-491.
16. Prasongsukarn K, Jamieson WR, Lichtenstein SV. Performance of bioprostheses and mechanical prostheses in age group 61-70 years. J Heart Valve Dis. 2005;14:501-8, 510.
17. van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, Grunkemeier GL, Bogers AJ, Takkenberg JJ. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137:881-6, 886e1.
18. L und O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg. 2006;132:20-26.
19. Ruel M, Chan V, Bédard P, Kulik A, Ressler L, Lam BK, Rubens FD, Goldstein W, Hendry PJ, Masters RG, Mesana TG. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults 60 years of age. Circulation,2007,116(11 Suppl)I294-I300
20. Mérie C, Køber L, Skov Olsen P, Andersson C, Gislason G, Skov Jensen J, Torp-Pedersen C. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA. 2012;308:2118-2125.
21. Chan V, Lam EK, Rubens FD, Hendry P, Masters R, Mesana TG, Ruel M. Long term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement. J Thorac Cardiovasc Surg. 2005;129:94-103.
22. Potter DD, Sundt TM 3rd, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, McGregor CG, Puga FJ, Schaff HV, Orszulak TA. Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg. 2005;129:94-103.
23. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med. 2000;133:687-695.
24. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689-2696.
25. Durrleman N, Pellerin M, Bouchard D, Hébert Y, Cartier R, Perrault LP, Basmadjian A, Carrier M. Prosthetic valve replacement: twenty year experience at the Montreal Heart Institute. J Thorac Cardiovasc Surg. 2004;127:1388-1392.
26. Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66(6 Suppl):S57-S61.
27. Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg. 2002;124:146-154.
28. Banbury MK, Cosgrove DM III, White JA, Blackstone EH, Frater RWM, Okies JE. Age and valve size effect on long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg. 2001;72:753-757.
29. McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, Aranki SF, Couper GS, Cohn LH. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg. 2010;89:1410-1416.
30. Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM, Marchand MA. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg. 1998;66(6 Suppl):S143-S147.
31. Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE. Twenty year results of the Hancock II bioprosthesis. J Heart Valv Dis. 2006;15:49-56.
32. Mykén PS, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg. 2009;137:76-81.
33. Birkmeyer NJ, Birkmeyer JD, Tosteson AN, Grunkemeier GL, Marrin CA, O'Connor GT. Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg. 2000;70:1946-1952.
34. Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol. 2010;55:2413-2426.
35. Chan V, Malas T, Lapierre H, Boodhwani M, Lam BK, Rubens FD, Hendry PJ, Masters RG, Goldstein W, Mesana TG, Ruel M. Reoperation of left heart valve bioprostheses according to age at implantation. Circulation. 2011;124(11 Suppl):S75-S80.
36. Bloomfield P, Kitchin AH, Wheatley DJ, Walbaum PR, Lutz W, Miller HC. A prospective evaluation of the Björk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses. Circulation. 1986;73:1213-1222.
37. Kaneko T, Nauta F, Borstlap W, McGurk S, Rawn JD, Cohn LH. The "no-dissection" technique is safe for reoperative aortic valve replacement with a patent left internal thoracic artery graft. J Thorac Cardiovasc Surg. 2012;144:1036-1040.
38. Jamieson WR, Burr LH, Miyagishima RT, Janusz MT, Fradet GJ, Ling H, Lichtenstein SV. Re-operation for bioprosthetic aortic structural failure-risk assessment. Eur J Cardiothorac Surg. 2003;24:873-878.
39. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
40. L eon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
41. Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A, Descoutures F, Hengstenberg C, Moat NE, Bekeredjian R, Napodano M, Testa L, Lefevre T, Guetta V, Nissen H, Hernández JM, Roy D, Teles RC, Segev A, Dumonteil N, Fiorina C, Gotzmann M, Tchetche D, Abdel-Wahab M, De Marco F, Baumbach A, Laborde JC, Kornowski R. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126:2335-2344.
42. Jamieson WR, von Lipinski O, Miyagishima RT, Burr LH, Janusz MT, Ling H, Fradet GJ, Chan F, Germann E. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J Thorac Cardiovasc Surg. 2005;129:1301-1308.
43. Potter DD, Sundt TM 3rd, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, McGregor CG, Puga FJ, Schaff HV, Orszulak TA. Risk of repeat mitral valve replacement for failed mitral valve prostheses. Ann Thorac Surg. 2004;78:67-72; discussion 67.
44. Jamieson WR, Burr LH, Miyagishima RT, Janusz MT, Fradet GJ, Lichtenstein SV, Ling H. Reoperation for bioprosthetic mitral structural failure: risk assessment. Circulation. 2003;108 Suppl 1:II98-I102.
45. Cohn LH, Aranki SF, Rizzo RJ, Adams DH, Cogswell KA, Kinchla NM, Couper GS, Collins JJ Jr. Decrease in operative risk of reoperative valve surgery. Ann Thorac Surg. 1993;56:15-20; discussion 20.
46. Cheung A, Webb JG, Barbanti M, Freeman M, Binder RK, Thompson C, Wood DA, Ye J. Five-Year Experience with Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve Dysfunction. J Am Coll Cardiol. 2013 [Epub ahead of print].
47. L indblom D, Lindblom U, Qvist J, Lundström H. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol. 1990;15:566-573.
48. U .S. National Center for Health Statistics, National Vital Statistics Reports, Deaths: Preliminary Data for 2008;59.
49. Puvimanasinghe JP, Takkenberg JJ, Eijkemans MJ, Steyerberg EW, van Herwerden LA, Grunkemeier GL, Habbema JD, Bogers AJ. Prognosis after aortic valve replacement with the Carpentier-Edwards pericardial valve: use of microsimulation. Ann Thorac Surg. 2005;80:825-831.
50. Khuri SF, Folland ED, Sethi GK, Souchek J, Oprian C, Wong M, Burchfiel C, Henderson WG, Hammermeister KE. Six month postoperative hemodynamics of the Hancock heterograft and the Björk-Shiley prosthesis: results of a Veterans Administration cooperative prospective randomized trial. J Am Coll Cardiol. 1988;12:8-18.
51. Guenzinger R, Eichinger WB, Hettich I, Bleiziffer S, Ruzicka D, Bauernschmitt R, Lange R. A prospective randomized comparison of the Medtronic Advantage Supra and St Jude Medical Regent mechanical heart valves in the aortic position: is there an additional benefit of supraannular valve positioning? J Thorac Cardiovasc Surg. 2008;136:462-471.
52. Totaro P, Degno N, Zaidi A, Youhana A, Argano V. Carpentier-Edwards PERIMOUNT Magna bioprosthesis: a stented valve with stentless performance? J Thorac Cardiovasc Surg. 2005;130:1668-1674.
53. Brown ML, Park SJ, Sundt TM, Schaff HV. Early thrombosis risk in patients with biologic valves in the aortic position. J Thorac Cardiovasc Surg. 2012;144:108-111.